FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20251125E00221
1. Date of relevant event: 25/11/2025
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02185
4. Name of listed corporation: Shanghai Bio-heart Biological Technology Co., Ltd. - B 
5. Class of shares: H Shares 
6. Number of issued shares in class: 235,703,422
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Wang
(Other names) Philip Li
10. Name of director (Chinese):  
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1101The number of shares in which you are interested has increased because:
you purchased the shares
 
 
2201Interest of corporation controlled by you
 
10,000  HKD  6.2200  6.2200   
 
Short position 
 
 
 
           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position84,967,70036.05
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position84,977,70036.05
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position15,700,710
2201Interest of corporation controlled by you
Long position23,481,406
2201Interest of corporation controlled by you
Long position45,795,584
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
上海百心安通企业管理咨询合伙企業(有限合伙)上海市青浦区五厍浜路203号13幢五层幢五层D区514室(中华人民共和国)Philip Li Wang100.00Y
Long position15,700,710
上海百哈特企业管理咨询合伙企业(有限合伙)上海市青浦区青湖路1023号711室I区23(中华人民共和国)Philip Li Wang100.00Y
Long position23,481,406
Winning Powerful LimitedRoom 1703, 17th Floor, Tai Tung Building, No. 8 Fleming Road, Wan Chai, Hong Kong(Hong Kong Special Administrative Region of the People's Republic of China)Philip Li Wang100.00Y
Long position45,795,584
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Box 30: Peili Wang is the sole executive partner of 上海百哈特企業管理諮詢合夥企業(有限合夥) with 1.62% partnership interest. Pursuant to a proxy agreement dated December 10, 2020, Philip Li Wang was appointed as 上海百哈特企業管理諮詢合夥企業(有限合夥)'s proxy to exercise its shareholder's rights, including voting rights. Philip Li Wang is the sole executive partner of 上海百心安通企業管理諮詢合夥企業(有限合夥).
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 25/11/2025
(dd/mm/yyyy)